Immunovant Inc (IMVT)
$29.17 -1.59% Close Oct 30, 2026 Live
Immunovant stock today
Immunovant closed at $29.17 on October 30, 2026, down 1.59% on the day. Over the past year it returned +17.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $5.99 billion.
$30.00$40.00
NovJan 2026MarMayJulSep
| Period | IMVT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -13.6% | -0.9% |
| 3 months | -26.1% | +2.1% |
| Year to date | +14.8% | +11.7% |
| 1 year | +17.5% | +12.4% |
| 3 years | -11.4% | +88.5% |
| 5 years | +262.8% | +76.0% |
Key statistics
- Market value
- $5.99B
- 52-week range
- $22.02 to $44.96
- Next report
- Nov 9, 2026
About Immunovant
Develops monoclonal antibody therapies for autoimmune and oncology diseases.
Sector: Health Care
More on Immunovant
- Returns: what $1,000 became$1,000 five years ago is $3,628 today
No forecast, no recommendation. This page describes Immunovant Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.